AI-guided HLA peptide characterization and absolute quantification platform for biotech and pharma, enabling target discovery and validation for TCR/TCRm immunotherapies. Includes sensitive neoantigen detection (NeoZoom), a SaaS quantitative HLA peptide database with off-target/safety tools (HLA-Compass), and HLA class II profiling for immunogenicity risk assessment.